Drug class
Mast-cell stabiliser; anti-allergic agent (cromoglicic acid)
Mechanism of action
Inhibits activation and mediator release from sensitised mast cells and other inflammatory cells. The precise molecular mechanism is not fully established; it acts prophylactically and is not a rapid bronchodilator. Sodium cromoglicate is a salt of the same active moiety.
General use cases
- Prevention of bronchial asthma symptoms with inhaled formulations
- Treatment or prevention of allergic rhinitis with nasal formulations
- Relief of allergic conjunctivitis with ophthalmic formulations
- Selected systemic use for mastocytosis with oral formulations; use is route- and product-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
